School and Work Absences After Critical Care Hospitalization for Pediatric Acute Respiratory Failure: A Secondary

Erin F Carlton1,2, John P Donnelly3, Hallie C Prescott4,5

  • 1Division of Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor.

JAMA Network Open
|December 23, 2021
PubMed

Insights

Two-thirds of children hospitalized for acute respiratory failure missed school post-discharge, with a median absence of nearly two weeks. Over half of their caregivers also missed work, highlighting potential long-term impacts on education and economic stability.

Area of Science:

  • Pediatric critical care medicine
  • Public health
  • Epidemiology

Background:

  • Pediatric critical illness survivors and their caregivers often face long-term physical, emotional, and cognitive challenges.
  • The extent of school and work absenteeism following pediatric critical illness is not well-documented.

Purpose of the Study:

  • To quantify the rates and duration of school absence in children surviving acute respiratory failure.
  • To determine the rates and duration of work absence among their primary caregivers.

Main Methods:

  • Secondary analysis of the RESTORE cluster randomized trial data.
  • Follow-up assessments at 6 months post-pediatric intensive care unit (PICU) discharge for 960 survivors.
  • Caregiver-reported data on school and work absenteeism, with risk factor analysis.

Main Results:

  • Nearly 70% of school-enrolled survivors (279/399) missed school, with a median absence of 16.9 days.
  • Over half of employed caregivers (277/506) missed work, with a median absence of 8 days.
  • Older age (≥5 years) and pre-existing comorbidities were associated with increased school absence duration.

Conclusions:

  • Significant school and work absenteeism occurs after pediatric acute respiratory failure hospitalization.
  • This absenteeism may contribute to adverse long-term outcomes, including educational deficits and economic hardship.
  • Further research and interventions are needed to mitigate these post-discharge consequences.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
422
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
266
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
232
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
377
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
386